Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks.
Alberts SR, Erlichman C, Sloan J, Okuno SH, Burch PA, Rubin J, Pitot HC, Goldberg RM, Adjei AA, Atherton PJ, Kaufmann SH.
Alberts SR, et al. Among authors: okuno sh.
Ann Oncol. 2001 May;12(5):627-31. doi: 10.1023/a:1011140818150.
Ann Oncol. 2001.
PMID: 11432620
Free article.
Clinical Trial.